OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Facial Numbness, Dysarthria, Muscle Atrophy, and Weakness in a Young Patient	461
Adequate Initial Dosage and Tapering Methods of Steroids to Reduce the Total Corticosteroid Dose in Myasthenia Gravis	426
Diplopia and Ptosis in an Older Woman	375
Early Posttraumatic Seizures—Putting Things in Perspective	371
Rizatriptan vs Placebo for Attacks of Vestibular Migraine	321
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	321
Origin of Transthyretin in Cerebral Amyloid Angiopathy	267
Error in Author Name	214
Equipping AI for Unbiased and Inclusive Neurology	205
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	203
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	197
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	196
Automated Imaging Differentiation for Parkinsonism	189
Somebody to Love	188
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	188
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	185
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	184
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	182
Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up	182
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis	179
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	173
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	170
JAMA Neurology	163
Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis	161
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	158

Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	150
Time to Change the Current Clinical Classification of Multiple Sclerosis?	150
JAMA Neurology	149
Is It Really Itching?	148
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	139
The Neurologist’s Imperative in Brain Death	138
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	132
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	132
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	129
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	124
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	123
Error in Abstract	122
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	122
Do Neurologists Need a Goldwater Rule?	119
Methylphenidate for Apathy in Alzheimer Disease—Why Should We Care?	117
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	115
Disentangling Workflow Paradigms and Treatment Decision-making in Acute Ischemic Stroke	112
Error in Figure	110
Error in Additional Contributions	109
Histologic Anatomy of Neurocysticercosis	109
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	106
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	98
Is It Really Itching?—Reply	98
Sleep Recording for the Diagnosis and Treatment of Paraplegia	98
JAMA Neurology	97
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	97
Error in Figure	93
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	91
Visual Neglect After an Isolated Lesion of the Superior Colliculus	91
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke	90
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	90
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	88
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	87
Role of the X Chromosome in Alzheimer Disease Genetics	87
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	86
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	85
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	85
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	84
Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion	83
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum	83
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	82
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	81
Acute Myelopathy in a Man With Cutaneous Papules	80
JAMA Neurology	77
Error in Text	76
Magnetic Resonance Imaging Features of GABA-A Receptor Antibody-Mediated Encephalitis	76
JAMA Neurology	76
Perceived CTE and Suicidality—Is Perception Reality?	75
Error in Key for Figure 3	75
Error in Figures	75

Peripheral-Type Facial Paralysis and Unilateral Hemisphere Hemorrhage